Molecular Pharmacology Journal Club
2/27/2020 - 10:45 AM-11:45 AM
"First Selective 12-LOX Inhibitor, ML355, Impairs Thrombus Formation and Vessel Occlusion In Vivo With Minimal Effects on Hemostasis"

Andrew Lamade

Thomas E. Starzl Biomedical Science Tower
1395 Conference Room
203 Lothrop Street
Pittsburgh, PA 15213
Shannon Granahan
QR Code for Event

Student News

Recent Publications

Program Achievements

Molecular Pharmacology Graduate Program Ranked #2 in National Research Council Rankings


Time to dissertation Defense
, last five graduating classes:  4.6 years, Completion Rate: 86.49%

First Author Publications (All students, past 5 year mean):  2.03;   Total Publications: 5.10

F-series Grants (F30/F31) (All Students, past 5 year mean):  12/34 (35%) 

Ranked #6 in National of Institute of Health funding of departments of Pharmacology

Ranked in the top 15 in funding for twenty-two consecutive years